Halloran Consulting Group Promotes Katie McCarthy to Chief Development Officer

Tue, Jun 4th 2019
Boston, MA
SHARE

McCarthy’s promotion comes as the firm enjoys substantial growth and opens a new office in San Diego, CA

Her ability to provide critical strategic insight to life science companies while right-sizing a development team, is invaluable. We’re excited to see her thrive in her new role.

BOSTON (PRWEB) JUNE 04, 2019

Halloran Consulting Group, a consulting firm for life science companies, today announces the promotion of Katie McCarthy to Chief Development Officer (CDO) and Managing Director. McCarthy’s promotion comes as the firm enjoys substantial growth and opens a new office in San Diego, CA. 

“Katie has continually proven herself to be a vital asset to Halloran’s success and continued growth,” said Laurie Halloran, President and CEO of Halloran Consulting Group. “Her ability to provide critical strategic insight to life science companies while right-sizing a development team, is invaluable. We’re excited to see her thrive in her new role.”

McCarthy brings more than 20 years of experience in drug development, beginning her career with Halloran in 2011 as a Senior Consultant. In her new role as CDO, she will provide strategic leadership to the development teams who support a broad and diverse portfolio of life sciences companies in the areas of clinical, regulatory, quality and program leadership. Since the beginning of 2018, McCarthy’s team has held 17 Food and Drug Administration (FDA) meetings, filed 16 Investigational New Drug (IND) applications, 8 special designations (Orphan, Fast Track, Breakthrough), filed one BLA, and managed a number of EU scientific meetings. They are currently serving as a development partner for over 50 clinical stage programs. Halloran’s development services are a key element to the firm’s continued success and growth. 

“I’m honored to move into this new role at Halloran,” says McCarthy. “The life science industry is experiencing incredible growth and development with truly life changing therapies becoming reality. I am grateful that our teams have the opportunity to contribute to so many high promise programs, it’s tremendously rewarding.” 

McCarthy began her career in clinical research at Mass General Hospital’s Memory and Movement Disorders Unit in 1997. She joined Biogen in 1999 and held several progressive leadership roles in Clinical, Medical Research, Organizational Effectiveness, and Program and Alliance Management. Today, she is an active member of the life science community and serves as an Advisory Board member for Life Science Cares.

About Halloran Consulting Group 
Halloran Consulting Group is a life science regulatory, quality and clinical consulting firm that provides deep and broad domain expertise tailored to each client relationship. The firm is a trusted partner and subject matter expert, proven by its track record across a long-standing and diverse client base. In working with one of the most expansive and relevant clinical pipelines in the industry, Halloran empowers its clients with the knowledge and strategies needed to achieve their next developmental milestone and optimize their organizations.

Halloran is certified by the Women’s Business Enterprise National Council as a woman-owned business. For more information, please visit http://www.hallorancg.com and follow us on Twitter at @HalloranConsult.

Press Contact: 
Sarah Silvestriadis 
Matter Communications 
halloran@matternow.com 
O: 978.518.4546